La Vague Archives - Page 4 of 11 - A3P - Pharmaceutical & Biotechnology Industry

La Vague

Container Closure Requirements in the New EU GMP Annex 1 – Enabling Compliance with a Holistic Science-Based Approach

October 2023 La Vague n°79 Special A3P Congress 2023 : Annex 1, Environmental and process monitoring Download the original issue Sommaire ✻ EU GMP Annex 1 (2022): Aseptic Process Simulation [...]

La Vague

Implementation of decontamination processes in the pharmaceutical industry

October 2023 La Vague n°79 Special A3P Congress 2023 : Annex 1, Environmental and process monitoring Download the original issue Sommaire ✻ EU GMP Annex 1 (2022): Aseptic Process Simulation [...]

La Vague

Introduction to the dual chamber systems (DCS) filling process

October 2023 La Vague n°79 Special A3P Congress 2023 : Annex 1, Environmental and process monitoring Download the original issue Table of Contents ✻ EU GMP Annex 1 (2022): Aseptic [...]

La Vague

EU GMP Annex 1 (2022): Aseptic Process Simulation (APS). New challenges for the pharmaceutical industry?

October 2023 La Vague n°79 Special A3P Congress 2023 : Annex 1, Environmental and process monitoring Download the original issue Table of Contents ✻ EU GMP Annex 1 (2022): Aseptic [...]

La Vague

Maximizing Sterility Assurance: Sterile Hold Time Testing for Sterilized Items Used in Parenteral Drug Manufacturing

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

La Vague

Development of a new preventive approach to reduce microbial infections with metal oxide nanoparticles

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

La Vague

The magnetic power of nanoparticles: magnetic cell sorting, decontamination of environments and reusable nanocatalysts

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

La Vague

Are modern scalable bioreactors the Cell Culture Strategy needed for Gene & Cell Therapy success?

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

La Vague

Overcoming Challenges in the development of lentiviral vector Manufacturing Platforms

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

La Vague

Overcoming obstacles in downstream bioprocessing of AAV based gene Therapy Products

April 2023 La Vague n°77 Gene Therapy Download the original issue Sommaire ✻ Gene therapy manufacturing comes of age: Commercial-scale manufacturing is imminent. Are gene therapy innovators ready? Overcoming obstacles [...]

1
2
3
4
5
…
10
11

In order to offer the best possible service, A3P uses cookies. By continuing to browse this website, you confirm to agree with their use.

I agree - Find out more

LINK10

Copy this code in your event registration form to receive an exclusive gift upon your arrival!

This code must be copied in the "Additional Information" field in the event registration form:

Additionnal Information